Loading chat...
AR HB1332
Bill
Status
5/5/2025
Primary Sponsor
Aaron Pilkington
Click for details
AI Summary
-
Arkansas Medicaid Program must cover glucagon-like peptide-1 receptor agonists (GLP-1 agonists) when prescribed for weight loss
-
Department of Human Services required to apply for any federal waiver, state plan amendment, or other authorization necessary to implement coverage
-
Health benefit plans offered, issued, or renewed in Arkansas must provide coverage for GLP-1 agonists when prescribed for weight loss after January 1, 2026
-
Government self-insured plan coverage is subject to the same health benefit plan provisions that apply to other covered services
Legislative Description
To Require The Arkansas Medicaid Program To Evaluate Claims For Diagnoses Frequency Of Obesity-related Conditions And Present The Costs.
Last Action
Died in Senate Committee at Sine Die adjournment.
5/5/2025